Fig. 7.

Delivery of miR-26a in vivo did not alter miR-26a, EphA2, or permeability. Mice were treated with 100 µl of PBS or 0.1 U of bleomycin in 100 µl of PBS followed by 40 µg of miR-26a mimic 4 days after treatment. Lungs and bronchoalveolar lavage fluid collected 7 days after treatment. Lung miR-26a (A) and EphA2 (B) at 7 days. C: alveolar cell count at 7 days. Data displayed as means ± SE; n = 5, *P < 0.05 compared with PBS treated groups by two-way ANOVA followed by Tukey’s post hoc analysis. U6, small nuclear RNA U6; 18S, ribosomal protein 18S.